Correlation Between Agilent Technologies and Structure Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Structure Therapeutics American, you can compare the effects of market volatilities on Agilent Technologies and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Structure Therapeutics.

Diversification Opportunities for Agilent Technologies and Structure Therapeutics

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Agilent and Structure is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Structure Therapeutics go up and down completely randomly.

Pair Corralation between Agilent Technologies and Structure Therapeutics

Taking into account the 90-day investment horizon Agilent Technologies is expected to under-perform the Structure Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Agilent Technologies is 3.99 times less risky than Structure Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Structure Therapeutics American is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,500  in Structure Therapeutics American on August 28, 2024 and sell it today you would earn a total of  1,901  from holding Structure Therapeutics American or generate 126.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy92.32%
ValuesDaily Returns

Agilent Technologies  vs.  Structure Therapeutics America

 Performance 
       Timeline  
Agilent Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agilent Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Agilent Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Agilent Technologies and Structure Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agilent Technologies and Structure Therapeutics

The main advantage of trading using opposite Agilent Technologies and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.
The idea behind Agilent Technologies and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.